The Pediatric Heart Network: A primer for the conduct of multicenter studies in children with congenital and acquired heart disease

Pediatric Cardiology

Volumn 27, Issue 2, 2006, Pages 191-198

  Mahony, L ^a,k   Sleeper, L A ^b   Anderson, P A W ^c   Gersony, W M ^d   McCrindle, B W ^e   Minich, L L ^f   Newburger, J W ^g   Saul, J P ^h   Vetter, V L ⁱ   Pearson, G D ^j  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^j NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^k CHILDREN S MEDICAL CENTER   (United States)

more..

Author keywords

Clinical trials; Congenital heart disease; Pediatric clinical research

Indexed keywords

ACETYLSALICYLIC ACID; ENALAPRIL; IMMUNOGLOBULIN; METHYLPREDNISOLONE; STEROID;

BLALOCK TAUSSIG ANASTOMOSIS; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG SAFETY; ECHOCARDIOGRAPHY; EVIDENCE BASED MEDICINE; FONTAN PROCEDURE; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEART DISEASE; HEART SINGLE VENTRICLE; HEART SURGERY; HEMODYNAMICS; HUMAN; INFORMATION PROCESSING; MEDICAL LITERATURE; METHODOLOGY; MITRAL VALVE REGURGITATION; MUCOCUTANEOUS LYMPH NODE SYNDROME; NORWOOD PROCEDURE; PATIENT SAFETY; PRACTICE GUIDELINE; QUALITY CONTROL; QUALITY OF LIFE; RESEARCH ETHICS; REVIEW; SAMPLING; TREATMENT OUTCOME;

CHILD; CLINICAL TRIALS; HEART DEFECTS, CONGENITAL; HEART DISEASES; HUMANS; MULTICENTER STUDIES; PATIENT SELECTION; RESEARCH DESIGN; SAMPLE SIZE; UNITED STATES;

EID: 33645115649     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-005-1151-9     Document Type: Review

References (16)

1. Borer JS (2004) Development of cardiovascular drugs. J Am Coll Cardiol 44:2285-2292
2. Bucher HC, Guyatt GH, Cook DJ, Holbrook A, McAlister FA (1999) Users' guide to the medical literature XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate endpoints. J Am Med Assoc 282:771-778
3. Caldwell PHY, Murphy SB, Burow PN, Craig JC (2004) Clinical trials in children. Lancet 364:803-811
4. De Amici D, Kiersy C, Ramajoli F, Brustia L, Politi P (2000) Impact of the Hawthorne effect in a longitudinal clinical study: the case of anesthesia. Controlled Clinical Trials 21:103-114
5. DeMets DL, Califf RM (2002) Lessons learned from recent cardiovascular clinical trials; part I. Circulation 106:746-751
6. Ehrenkranz RA, Wright LL (2003) NICHD neonatal research network: contributions and future challenges. Semin Perinatol 27:264-280
7. Lenfant C (2002) Report of the Task Force Report on Research in Pediatric Cardiovascular Disease. Circulation 106:1037-1042
8. McCrindle BW (2005) Optimizing outcomes through clinical research and evidence-based decision-making. Prog Pediatr Cardiol 20:53-64
9. National Heart, Lung, and Blood Institute (2000) RFA for Pediatric Heart Disease Clinical Research Network. Available at http://grants.nih.gov/grants/ rfa-files/RFA-HL-00-013.html. Accessed May 24, 2000
10. Packer M (2001) Proposal for a new clinical endpoint to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Cardiac Failure 7:176-182
11. Silber JH (2005) Challenges in conducting a pediatric longitudinal prevention study: lessons from the ACE-inhibitor after anthracycline trial. Prog Pediatr Cardiol 20:65-70
12. Sinaiko AR, Lauer RM, Sanders SP (2001) End points for cardiovascular drug trials in pediatric patients. Am Heart J 142:229-232
13. Strand M, Jobe AH (2003) The multiple negative randomized controlled trials in perinatology - why? Semin Perinatol 27:343-350
14. Sung NS, Crowley WF Jr, Genel M, et al. (2003) Central challenges facing the national clinical research enterprise. J Am Med Assoc 289:1278-1287
15. Thom EA, Rouse DJ (2003) What we have learned about conducting randomized controlled trials in the NICHD MFMU network. Semin Perinatol 27:253-260
16. Zhang B, Schmidt B (2001) Do we measure the right endpoints? A systematic review of primary outcomes in recent neonatal randomized controlled clinical trials. J Pediatr 138:76-80